hepatocellular carcinoma case report oldest patient

by Mr. Benedict Rath IV 8 min read

A case of hepatocellular carcinoma in an elder man with …

28 hours ago  · In this report, we have described a 50-year-old male patient with hepatocellular carcinoma had nasopharynx metastases two months after his initial diagnosis and interventional treatment, indicating that though nasopharynx metastasis of the hepatocellular carcinoma is relatively low, it really occurs. >> Go To The Portal


A case of a 62-year-old patient with hereditary hemochromatosis is reported, who developed hepatocellular carcinoma (HCC

Hepatocellular Carcinoma

The most common form of liver cancer often seen in people with chronic liver diseases like cirrhosis.

) in the absence of cirrhosis

Cirrhosis of the Liver

A degenerative disease of the liver resulting in scarring and liver failure.

and other potential risk factors for HCC.

Full Answer

What is the first clinical sign of hepatocellular carcinoma (HCC)?

Amador A, Monforte NG, Bejaran ON, Martí J, Artigau E, Navarro S, Fuster J. Cutaneous metastasis from hepatocellular carcinoma as the first clinical sign. J Hepatobiliary Pancreat Surg. 2007;14:328–330.

What is hepatocellular carcinoma (SHC)?

Sarcomatoid hepatocellular carcinoma (SHC) is a rare malignant hepatic tumor. Recurrent interventional therapies such as transcatheter arterial chemo-embolization (TACE), radiofrequency ablation (RFA), and percutaneous ethanol injection have been reported previously utilized in a majority of SHC cases.

What is the prognosis of sarcomatoid hepatocellular carcinoma?

Sarcomatoid hepatocellular carcinoma (SHC) is a rare neoplasm of the liver, accounting for 1.8–2.0% of all patients undergoing surgery [ 4, 5 ]. The diagnosis of SHC requires postoperative pathological examination, while the preferred therapy is surgical excision. The prognosis of SHC remains very poor due to frequent recurrence and metastasis.

Is hepatocellular carcinoma with metastases to the gingiva a unique presentation?

This case report is important because we demonstrate a unique presentation of hepatocellular carcinoma (HCC) with metastases to the gingiva and likely the penis. A review of the literature demonstrates the rarity of this presentation.

How old are most liver cancer patients?

Although liver cancer can happen at any age, it is most common in older people. Most people diagnosed are over the age of 60. The highest rates are in 85 to 89 year olds.

Who is at risk for hepatocellular carcinoma?

Major risk factors for HCC include chronic alcohol consumption, hepatitis B, hepatitis C and non-alcoholic fatty liver disease [3]. Other, less common causes are Wilson's disease, hereditary hemochromatosis, alpha1-antitrypsin deficiency, primary biliary cirrhosis and autoimmune hepatitis [4, 5].

How is hepatocellular carcinoma treated in the elderly?

The current treatments for HCC with established efficacy include: (1) surgical resection (SR)/liver transplantation (LT); (2) transcatheter arterial chemoembolization (TACE); (3) percutaneous radiofrequency ablation (RFA); (4) percutaneous ethanol injection (PEI); (5) percutaneous microwave coagulation therapy (PMCT); ...

Is hepatocellular carcinoma a death sentence?

Hepatocellular carcinoma (HCC) is a complex disease and a major cause of death in high endemic areas of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. HCC has gone from being a universal death sentence to a cancer that can be prevented, detected at an early stage and effectively treated.

What is the most common cause of hepatocellular carcinoma?

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection.

Is hepatocellular carcinoma hereditary?

No. However, one of the risk factors for developing hepatocellular carcinoma is hereditary hemochromatosis, which does have a genetic association. Liver tumors may be primary (originating from the liver) or metastatic (spread from a cancer elsewhere).

How long can you live after TACE?

The overall median survival of the TACE group (8.0 months) was significantly longer than that of the non-TACE (2.0 months; P ≤ . 01). Of the patients at BCLC-C and Child-Pugh-B, the overall median survivals of the TACE and non-TACE patients were 6.0 and 2.0 months, respectively (P ≤ .

Can HCC be cured?

If caught early, it can sometimes be cured with surgery or transplant. In more advanced cases it can't be cured, but treatment and support can help you live longer and better.

How long can you live with a tumor on your liver?

Without treatment, the median survival for stage A liver cancer is 3 years. With treatment, between 50 and 70 out of 100 people (between 50 – 70%) will survive for 5 years or more.

How fast does HCC spread?

The estimated time needed for a HCC to grow from 1 cm to 2 cm was 212 days in patients with HBV infection and 328 days in those with HCV infection.

What are the common causes of death of patients with hepatocellular carcinoma?

The immediate cause of death was tumor progression in 40 patients; cirrhosis complications in 23 patients; treatment related complications in 6 and infectious complications in 14. Tumor related deaths were as follows: BCLC A 7 deaths; BCLC B 6 deaths, BCLC C 26 deaths and BCLC D 18 deaths.

Is hepatocellular carcinoma fatal?

Hepatocelluar carcinoma, a type of liver cancer, is deadly. Even in the best-case scenario -- a localized tumor detected before it spreads from the liver -- the five-year survival rate is only 33 percent.